Design
Review
Answers are grounded in this paper and cite their sources.
May aid recognition of paroxysmal tachycardia in polyuria; leaves open mechanistic validation in prospective studies.
Article1 September 1966Paroxysmal Tachycardia with PolyuriaMYRON H. LURIA, M.D., EDWARD I. ADELSON, M.D., SOMCHART LOCHAYA, M.D.MYRON H. LURIA, M.D., EDWARD I. ADELSON, M.D., SOMCHART LOCHAYA, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-65-3-461 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAlthough familiar to many physicians, the polyuria associated with paroxysmal tachycardia is a phenomenon which has received insufficient attention until recently. Wenckebach and Winterberg (1) found that "For many cases, polyuria preceding or associated with an attack, is quite typical with excretion of large amounts of light urine of low specific gravity." They termed it "urina spastica." However, the diuresis has received only brief mention in several standard textbooks (2-5) and somewhat more attention by Jones (6), Spang (7) and Scherf and Boyd (8). The current clinical awareness of this remarkable renal response to paroxysmal tachycardia is principally the result...References1. WENCKEBACHWINTERBERG KFH: Die unregelmässige Hertztätigkeit. Verlag von Wilhelm Engelmann, Leipzig, 1927, p. 252. Google Scholar2. WHITE PD: Heart Disease, 4th ed. Macmillan, New York, 1951, p. 883. Google Scholar3. FRIEDBERG CK: Diseases of the Heart, 2nd ed. W. B. Saunders Co., Philadelphia and London, 1956, p. 347. Google Scholar4. KATZPICK LNA: Clinical Electrocardiography: Part I. The Arrhythmias. Lea & Febiger, Philadelphia, 1956, pp. 276-277. Google Scholar5. WOOD P: Diseases of the Heart and Circulation, 2nd ed. J. B. Lippincott, Philadelphia, 1956, p. 237. Google Scholar6. JONES GM: Paroxysmal auricular tachycardia: Observations in 47 cases. Ann. Intern. Med. 40: 581, 1954. LinkGoogle Scholar7. SPANG K: Rhythmusstörungen des Herzens, Georg Thieme Verlag, Stuttgart, 1957, p. 163. Google Scholar8. SCHERFBOYD DLJ: Cardiovascular Diseases, 3rd ed. Grune & Stratton, New York and London, 1958, p. 658. Google Scholar9. WOOD P: Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation. Brit. Heart J. 25: 273, 1963. CrossrefMedlineGoogle Scholar10. BORST JG: The maintenance of an adequate cardiac output by the regulation of the urinary excretion of water and sodium chloride: An essential factor in the genesis of edema. Acta Med. Scand. (suppl.) 207: 1, 1948. Google Scholar11. BORST JG: The Characteristic Renal Excretion Patterns Associated with Excessive or Inadequate Circulation. Ciba Foundation Symposium on the Kidney. Little, Brown and Co., Boston, 1954, pp. 255-284. CrossrefGoogle Scholar12. GHOSEJOCKESKYRIACOU RRAMEH: Renal response to paroxysmal tachycardia. Brit. Heart J. 27: 684, 1965. CrossrefMedlineGoogle Scholar13. KILBURN KH: Diuresis with paroxysmal tachycardia. Circulation 28: 749, 1963. Google Scholar14. BOUCHERVEYRATCHAMPLAINGENEST RRJDJ: New procedures for measurement of human plasma angiotensin and renin activity levels. Canad. Med. Ass. J. 90: 194, 1964. MedlineGoogle Scholar15. COHNLURIA JNMH: Studies in clinical shock and hypotension: The value of bedside hemodynamic observations. JAMA 190: 891, 1964. CrossrefMedlineGoogle Scholar16. KINSMANMOOREHAMILTON JMJWWF: Studies on the circulation: injection method. physical and mathematical considerations. Amer. J. Physiol. 89: 322, 1929. CrossrefGoogle Scholar17. ROWLANDSHOWITTMARKMAN DJGP: Propranolol (Inderal) in disturbances of cardiac rhythm. Brit. Heart J. 1: 891, 1965. Google Scholar18. HARRISONGRIFFINFIENE DCJRTJ: Effects of beta-adrenergic blockade with propranolol in patients with atrial arrhythmias. New Eng. J. Med. 273: 410, 1965. CrossrefMedlineGoogle Scholar19. BLACKCROWTHERSHANKSSMITHDORNHORST JWAFRGLHAC: A new adrenergic betareceptor antagonist. Lancet 1: 1080, 1964. CrossrefMedlineGoogle Scholar20. FERRERHARVEYWEINERCATHCARTCOURNAND MIRMHMRIA: Hemodynamic studies in two cases of Wolff-Parkinson-White syndrome with paroxysmal A-V nodal tachycardia. Amer. J. Med. 6: 725, 1949. CrossrefMedlineGoogle Scholar21. SAUNDERSORD DEJW: The hemodynamic effects of paroxysmal supraventricular tachycardia in patients with the Wolff-Parkinson-White syndrome. Amer. J. Cardiol. 9: 223, 1962. CrossrefMedlineGoogle Scholar22. GAUERHENRYSIEKERWENDT OHJPHOWE: The effect of negative pressure breathing on urine flow. J. Clin. Invest. 33: 287, 1954. CrossrefMedlineGoogle Scholar23. HENRYPEARCE JPJW: The possible role of cardiac atrial stretch receptors in the induction of changes in urine flow. J. Physiol. 131: 572, 1956. CrossrefMedlineGoogle Scholar24. HENRYGAUERREEVES JPOHJL: Evidence of the atrial location of receptors influencing urine flow. Circ. Res. 4: 85, 1956. CrossrefMedlineGoogle Scholar25. PEARCE JW: A current concept of the regulation of blood volume. Brit. Heart J. 23: 66, 1961. CrossrefMedlineGoogle Scholar26. GAUERHENRYSIEKER OHJPHO: Cardiac receptors and fluid volume control. Progr. Cardiov. Dis. 4: 1, 1961. CrossrefMedlineGoogle Scholar27. ARNDTREINECKGAUER JOHOH: Ausscheidungsfunktion und Hämodynamik der Nieren bei Dehnung des linken Vorhofes am narkotisierten Hund. Pflueger Arch. Ges. Physiol. 277: 1, 1963. CrossrefGoogle Scholar28. GILMOREWEISFELDT JPML: Contribution of intravascular receptors to the renal responses following intravascular volume expansion. Circ. Res. 17: 144, 1965. CrossrefMedlineGoogle Scholar29. BRICKERMORRINKIME NSPASW: The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis." Amer. J. Med. 28: 77, 1960. CrossrefMedlineGoogle Scholar30. GANNTRAVIS PSRH: Mechanisms of hemodynamic control of secretion of aldosterone in the dog. Amer. J. Physiol. 207: 1095, 1964. CrossrefMedlineGoogle Scholar31. LYDTINHAMILTON HWF: Effect of acute changes in left atrial pressure on urine flow in unanesthetized dogs. Ibid., p. 530. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: MYRON H. LURIA, M.D.; EDWARD I. ADELSON, M.D.; SOMCHART LOCHAYA, M.D.Affiliations: Chicago, IllinoisFrom the Cardiovascular Institute and Division of Cardiovascular Disease, Department of Medicine, Michael Reese Hospital and Medical Center, Chicago, Ill.This study was supported in part by grant HE-06375, National Heart Institute, National Institutes of Health, Bethesda, Md.Dr. Lochaya is a Postdoctorate Research Fellow in the Cardiovascular Institute of the Michael Reese Hospital and Medical Center, supported by training grant 5T1-HE-05252, National Heart Institute, National Institutes of Health, Bethesda, Md.Requests for reprints should be addressed to Louis N. Katz, M.D., Cardiovascular Institute, Michael Reese Hospital and Medical Center, Chicago, Ill. 60616. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe Endocrine Heart: Natriuretic Peptides and Oxygen Metabolism in Cardiac DiseasesTachycardia-polyuria syndrome after swan-ganz catheterization in liver transplant patient - A case report -Clinical presentation of paroxysmal supraventricular tachycardia: evaluation of usual and unusual symptomsDiagnostic challenges in supraventricular tachycardia: anticipating value of natriuretic peptidesAtrial Natriuretic Peptide and Its Potential Role in PharmacotherapyAtrial Natriuretic Factor: Implications for Cardiac Pacing and ElectrophysiologyAtrial regulation of intravascular volume: Observations on the tachycardia-polyuria syndromeCardiac Arrhythmias: Premature Beats and Paroxysmal TachycardiasPlasma Prohormone Atrial Natriuretic Peptides 1-98 and 31-67 Increase with Supraventricular and Ventricular ArrhythmiasConcentrations of plasma atrial natriuretic factor during and after reversion of ventricular tachycardia.Chronotropic stimulation: a primary effector for release of atrial natriuretic factor.Natriuresis associated with elevated plasma atrial natriuretic hormone during supraventricular tachycardiaProhormone atrial natriuretic peptides 1–30, 31–67, and 99–126 increase in proportion to right ventricular pacing rateAtrial natriuretic factor release is enhanced by incremental atrial pacingAkute rechtsatriale Drucksteigerung durch intrakardiale Stimulation erhöht den atrialen natriuretischen Faktor (ANF)Atrial natriuretic peptide in spontaneous tachycardias.Increase of human atrial natriuretic polypeptide in response to cardiac pacingAtrial natriuretic factor during atrial fibrillation and supraventricular tachycardiaPlasma levels of immunoreactive atrial natriuretic factor increase during supraventricular tachycardiaAtriopeptins as cardiac hormones.Plasma Concentration of Atrial Natriuretic Factor in a Patient with Paroxysmal Atrial TachycardiaDie rhythmogene HerzinsuffizienzNeural Control of Extracellular Volume in the Human and Nonhuman PrimateNatriuretic activity of human and monkey atria.Hämodynamische Auswirkungen kardialer ArrhythmienPolyuria from Tachycardia in an InfantHemodynamic Consequences of Cardiac DysrhythmiasThe contribution of atrial stretch receptors to salt and water homeostasis in the humanThe Polyuria of Paroxysmal Atrial TachycardiaLeft Atrial Receptor Discharge during Atrial Arrhythmias in the DogReflex Diuresis during Tachycardia in the DogRole of Mineralocorticoids in the Natriuresis of Water Immersion in Man 1 September 1966Volume 65, Issue 3 Page: 461-470 Keywords Cardiology and cardiovascular diseases Cardiovascular diseases Excretion Heart Hospital medicine Longitudinal studies Tachycardia Urine ePublished: 1 December 2008 Issue Published: 1 September 1966 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Myron H. Luria (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: